Clinical
Research Coordinator
Research for new drugs is an ongoing process. It is expensive, energy-consuming, and time-consuming.
An
investigational new drug (IND), a new health product, or a new treatment for an existing product must undergo strict research studies and tests before it is made available to the public. This can sometimes take up to fifteen years!
Clinical
trial management (research) is a stringently regulated process in
which human subjects (volunteers) participate in a research study.
- CenterWatch
More than 5,200
clinical trials are listed here, actively recruiting human
subjects. Search by therapeutic area and geographic region.
During these studies, human subjects are monitored by specific procedures that are outlined in the study's protocol (design). Data is collected and analyzed, based upon the protocol. Safety (how safe a study drug or a mechanical device is for the human subject) and efficacy (how well the drug or the device is in treatment) are monitored closely.
There are
typically four phases during a drug's development, during which
safety and efficacy are constantly monitored. The following are
simplified definitions:
- Phase
I ---
a study drug is given to healthy human subjects; GOAL: to see if the study drug is safe
- Phase
II ---
a study drug is given to human subjects with the specific disease;
GOAL: to see if the study drug is safe and if the study drug is effective against the specific disease
- Phase
III---
two drugs (the study drug and another similar drug) are compared
by giving the study drug to one group of human subjects with the
specific disease and an already established effective drug to
another group of human subjects with the specific disease; GOAL:
to see if the study drug is as effective or more effective than
the established drug
- Phase
IV ---
the study drug is made available to the public
ACRP
delineates separate definitions of two, among many, personnel who are
involved in the conduct of a study: Clinical Research Coordinator
(CRC) and Clinical Clinical Research
Associate (CRA).
A CRC is
employed on the study staff at a clinical site (a medical facility,
such as a doctor's office or a hospital) where the study is
conducted. Typically referred to as CRCs, these are study
coordinators, research nurses, or site managers. ACRP offers
certification and continuing education programs to members and
non-members.
SoCRA defines
a Clinical Research Associate (CRA) as someone who "functions as an
administrator, coordinator, consultant, educator, or researcher" in
clinical trial management. SoCRA offers certification and continuing
education programs for members and non-members.
DIA is an
organization in which health professionals exchange and share
information on the discovery, development, evaluation, and
utilization of health care medicines and technologies. The DIA
provides opportunities for continuing education to
professionals.
The CRA
Registry is an organization with whom auditors, monitors, data
reviewers and study coordinators can register their resumes for
potential employers such as CROs, Pharmaceutical sponsors, and
Medical Device companies.
There are
several organizations that monitor the participation and the safety
of human subjects in drug studies, as well as regulate the conduct of
research studies, worldwide. The International Conference on
Harmonisation is one organization in which regulatory authorities
from Europe, Japan and the United States join with experts from the
pharmaceutical industry to discuss scientific and technical aspects
of product registration. In the United States, The Food and Drug
Administration (FDA) regulates drug research and development
process. Institutional Review Boards (IRBs) are regional, state, or
local agencies that ensure the safety of human subjects.
The CRC
functions under the supervision of a principal
investigator (usually a physician) who is legally responsible for
the conduct of the study, as outlined by certain regulations of The
Food and Drug Administration (FDA). Guidelines to Good Clinical
Practices (GCPs) are followed to protect the rights and welfare of
human subjects and to ensure the quality, integrity and transparency
of data in clinical trials.
Some of the
many responsibilities of a CRC include:
- site
preparation (submitting appropriate documents to local IRBs,
ordering supplies, arranging facilities for the conduct of the
study, coordinating with local agencies, etc.)
- human
subject screening and recruitment (identifying potential human
subjects, obtaining medical histories, verifying that human
subjects meet the requirements for a study protocol)
- human
subject enrollment (explaining protocol
procedures to human subjects, directing appropriate questions to
principal investigator)
- maintaining and dispensing drug supplies (verifying that
human subjects are taking the study drug as directed by the
protocol, retrieving unused and used study drug and
containers)
- completing and ensuring the quality of case report
forms
(recording data accurately, transcribing collected data to
appropriate forms, storing data for a specified period of
time)
- maintaining source documents (writing
information for a specific patient in a medical chart)
- ensuring
site
quality (coordinating procedures and processes of a
protocol in a timely, efficient manner).
Many CRCs
perform additional duties:
- obtaining
vital
signs
(measuring blood pressure, heart rate, respirations rate,
temperature, height, and weight of a human subject)
- maintaining a medication log (recording
medications that a human subject takes during participation on the
study)
- obtaining labs (drawing blood, obtaining
urine, and preparing sputum samples from human subjects in the
study for protocol-specific tests)
- packaging
lab samples (following regulated handling procedures and
using specifically designed containers) for shipment to a
central lab (a contracted laboratory
facility) for analysis.
As you can
see, a CRC is a very important and active participant on the study
team.
Return to My Career

This page made with Claris Works 2.0.
This website was last updated 25-May-2002
Since March 1998, you are visitor number